» Articles » PMID: 23657113

Emergence of Avian Influenza A(H7N9) Virus Causing Severe Human Illness - China, February-April 2013

Overview
Date 2013 May 10
PMID 23657113
Citations 65
Affiliations
Soon will be listed here.
Abstract

On March 29, 2013, the Chinese Center for Disease Control and Prevention completed laboratory confirmation of three human infections with an avian influenza A(H7N9) virus not previously reported in humans. These infections were reported to the World Health Organization (WHO) on March 31, 2013, in accordance with International Health Regulations. The cases involved two adults in Shanghai and one in Anhui Province. All three patients had severe pneumonia, developed acute respiratory distress syndrome (ARDS), and died from their illness. The cases were not epidemiologically linked. The detection of these cases initiated a cascade of activities in China, including diagnostic test development, enhanced surveillance for new cases, and investigations to identify the source(s) of infection. No evidence of sustained human-to-human transmission has been found, and no human cases of H7N9 virus infection have been detected outside China, including the United States. This report summarizes recent findings and recommendations for preparing and responding to potential H7N9 cases in the United States. Clinicians should consider the diagnosis of avian influenza A(H7N9) virus infection in persons with acute respiratory illness and relevant exposure history and should contact their state health departments regarding specimen collection and facilitation of confirmatory testing.

Citing Articles

Modelling the transmission dynamics of H9N2 avian influenza viruses in a live bird market.

Pinotti F, Kohnle L, Lourenco J, Gupta S, Hoque M, Mahmud R Nat Commun. 2024; 15(1):3494.

PMID: 38693163 PMC: 11063141. DOI: 10.1038/s41467-024-47703-9.


Novel neuroendocrine role of γ-aminobutyric acid and gastrin-releasing peptide in the host response to influenza infection.

Shirey K, Lai W, Sunday M, Cuttitta F, Blanco J, Vogel S Mucosal Immunol. 2023; 16(3):302-311.

PMID: 36965691 PMC: 10330014. DOI: 10.1016/j.mucimm.2023.03.004.


H7N9 bearing a mutation in the nucleoprotein leads to increased pathology in chickens.

Layton D, Butler J, Stewart C, Stevens V, Payne J, Rootes C Front Immunol. 2022; 13:974210.

PMID: 36275684 PMC: 9583263. DOI: 10.3389/fimmu.2022.974210.


Message in a bottle: mRNA vaccination for influenza.

Shartouny J, Lowen A J Gen Virol. 2022; 103(7).

PMID: 35830333 PMC: 10027004. DOI: 10.1099/jgv.0.001765.


Why has the COVID-19 pandemic generated such global interest from the engineering community?.

Tang J, Licina D Indoor Air. 2022; 32(4):e13027.

PMID: 35481933 PMC: 9111545. DOI: 10.1111/ina.13027.


References
1.
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W . Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368(20):1888-97. DOI: 10.1056/NEJMoa1304459. View

2.
Uyeki T, Cox N . Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med. 2013; 368(20):1862-4. PMC: 6636320. DOI: 10.1056/NEJMp1304661. View

3.
. Update on human cases of influenza at the human – animal interface, 2012. Wkly Epidemiol Rec. 2013; 88(13):137-44. View

4.
Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J . Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013; 381(9881):1916-25. PMC: 7134567. DOI: 10.1016/S0140-6736(13)60903-4. View